Letteratura scientifica selezionata sul tema "Non coding variations"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Non coding variations".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Non coding variations"
Pan, Qi, Yue-Juan Liu, Xue-Feng Bai, Xiao-Le Han, Yong Jiang, Bo Ai, Shan-Shan Shi et al. "VARAdb: a comprehensive variation annotation database for human". Nucleic Acids Research 49, n. D1 (23 ottobre 2020): D1431—D1444. http://dx.doi.org/10.1093/nar/gkaa922.
Testo completoLaurent, Jon M., Sudarshan Pinglay, Leslie Mitchell e Ran Brosh. "Probing the dark matter of the human genome with big DNA". Biochemist 41, n. 3 (1 giugno 2019): 46–48. http://dx.doi.org/10.1042/bio04103046.
Testo completoSedláková, V., P. Sedlák, D. Zeka, J. Domkářová, P. Doležal e P. Vejl. "Evaluation of variations in plastid DNA non-coding regions in selected species of the genus Solanum". Czech Journal of Genetics and Plant Breeding 53, No. 3 (13 settembre 2017): 127–31. http://dx.doi.org/10.17221/76/2015-cjgpb.
Testo completoMeerschaut, Ilse, Sarah Vergult, Annelies Dheedene, Björn Menten, Katya De Groote, Hans De Wilde, Laura Muiño Mosquera et al. "A Reassessment of Copy Number Variations in Congenital Heart Defects: Picturing the Whole Genome". Genes 12, n. 7 (8 luglio 2021): 1048. http://dx.doi.org/10.3390/genes12071048.
Testo completoBhartiya, Deeksha, e Vinod Scaria. "Genomic variations in non-coding RNAs: Structure, function and regulation". Genomics 107, n. 2-3 (marzo 2016): 59–68. http://dx.doi.org/10.1016/j.ygeno.2016.01.005.
Testo completoBozgeyik, Esra, e Ibrahim Bozgeyik. "Non-coding RNA variations in oral cancers: A comprehensive review". Gene 851 (gennaio 2023): 147012. http://dx.doi.org/10.1016/j.gene.2022.147012.
Testo completoScarpa, Aldo, e Andrea Mafficini. "Non-coding regulatory variations: the dark matter of pancreatic cancer genomics". Gut 67, n. 3 (28 giugno 2017): 399–400. http://dx.doi.org/10.1136/gutjnl-2017-314310.
Testo completoHaas, Jan, Stefan Mester, Alan Lai, Karen S. Frese, Farbod Sedaghat‐Hamedani, Elham Kayvanpour, Tobias Rausch et al. "Genomic structural variations lead to dysregulation of important coding and non‐coding RNA species in dilated cardiomyopathy". EMBO Molecular Medicine 10, n. 1 (14 novembre 2017): 107–20. http://dx.doi.org/10.15252/emmm.201707838.
Testo completoSedano, Melina J., Alana L. Harrison, Mina Zilaie, Chandrima Das, Ramesh Choudhari, Enrique Ramos e Shrikanth S. Gadad. "Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs". International Journal of Molecular Sciences 21, n. 10 (25 maggio 2020): 3711. http://dx.doi.org/10.3390/ijms21103711.
Testo completoMattick, John S. "The central role of RNA in the genetic programming of complex organisms". Anais da Academia Brasileira de Ciências 82, n. 4 (dicembre 2010): 933–39. http://dx.doi.org/10.1590/s0001-37652010000400016.
Testo completoTesi sul tema "Non coding variations"
González, Rosado Santiago. "Identification and characterization of non-coding genomic variations associated to cancer diseases". Doctoral thesis, Universitat de Barcelona, 2016. http://hdl.handle.net/10803/397789.
Testo completoEl estudio de las bases genéticas y moleculares de las patologías humanas ha constituido el centro de atención de gran parte de la investigación en biología durante las últimas décadas con el fin último de comprender los procesos celulares alterados en cada caso y la posibilidad de generar protocolos de diagnosis y terapias específicas. Con la llegada de la denominada Next Generation Sequencing (NGS) y su consiguiente reducción en tiempo y costes ha permitido el acceso a la secuenciación de numeroso genomas humanos en el entorno biomédico. El estudio de enfermedades genéticas, y del cáncer en particular, se ha visto enormemente favorecido al poder incorporar un importante número de genomas de pacientes a sus estudios y así poder identificar directamente las mutaciones asociadas a cada patología. A su vez, esta revolución junto con la capacidad de detectar modificaciones genéticas en regiones cuya función todavía se desconoce, ha generado un doble desafío en la comunidad científica: por un lado el análisis de variantes genéticas asociadas a cada tipo de enfermedad y, por el otro, el entender el impacto funcional que dichas modificaciones provocan en la célula. Esta tesis contribuye a solucionar estas limitaciones a través del desarrollo de una aplicación, SMUFIN (Moncunill et al. 2014), que permite de forma rápida y eficaz la identificación de variaciones somáticas asociadas al desarrollo o progresión de tumores. También se describen los resultados obtenidos relativos a la identificación y caracterización de las reorganizaciones cromosómicas en cáncer, así como los resultados obtenido en cuanto a sus mecanismos e impacto funcional (Puente et al. 2015). Además, como parte de la anotación genómica para la interpretación funcional de las variaciones detectadas, esta tesis incluye los resultados del desarrollo de estrategias y metodologías para la detección de regiones reguladoras en genomas de eucariotas (Gonzalez et al. 2012). En resumen esta tesis intenta cubrir y dotar de herramientas bionformáticas para completar los pasos necesarios para el análisis de genomas en biomedicina, desde que un grupo de pacientes son secuenciados hasta que sus diferentes variantes son identificadas y su impacto funcional determinado. Este tipo de análisis, que ahora esta ocurriendo en el campo de la investigación, pronto será una realidad y una rutina en el sistema sanitario.
Masson, Aymeric. "Approches multi-omiques des anomalies transcriptionnelles dans les maladies rares du développement". Electronic Thesis or Diss., Bourgogne Franche-Comté, 2024. http://www.theses.fr/2024UBFCI006.
Testo completoGene expression occurs through the transcription process in the nucleus of eukaryotic cells, which produces RNAs, essential intermediates for protein formation. RNA synthesis and fate are controlled by a complex network of factors, among which are regulatory non-coding DNA sequences that ensure precise spatio-temporal regulation of gene expression and heterogeneous nuclear ribonucleoproteins (hnRNP), able to bind RNA molecules and contributing to their maturation, stability, and localization.The current standard approach for molecular exploration of patients with developmental disorders (DD) and/or intellectual disabilities (ID) uses a combination of chromosomal analysis using DNA microarrays, fragile X testing, exome sequencing, and more recently, genome sequencing to establish a molecular diagnosis. These approaches yield a diagnostic yield of less than 50% for DD/ID. However, the analyses sometimes reveal the presence of variations of uncertain significance in candidate genes not yet implicated in human pathology. Functional tests are then necessary to establish a correct genotype-phenotype correlation. In this way, pathogenic variations have been identified in two candidate genes encoding hnRNPs involved in RNA metabolism: PTBP1 and PTBP2. The aim of this first study is to describe the cellular pathophysiological mechanism related to transcriptional defects causing syndromic (for PTBP1) or non-syndromic (for PTBP2) neurodevelopmental impairment using in vitro and in vivo functional molecular approaches including RNA immunoprecipitation sequencing (RIP-seq) in a cohort of affected individuals.In some cases, genomic analysis identifiy complex structural variations that can disrupt the sequence of a dosage-sensitive gene, alter the activity of an enhancer, or exert position effects on gene expression by altering enhancer/target gene interactions. These molecular communications are facilitated within topological associating domains (TADs), which play an important role in tissue-specific transcriptional regulation. Consequently, any structural variation that reorganizes TADs (fusion, shuffling or even new TAD) can lead to an alteration in gene expression. In this context, the goal of this second research project is to characterize, through high-throughput chromosome conformation capture (Hi-C), the complex rearrangements in patients reorganizing the structure of TADs. Combined with other omic techniques such as long fragment sequencing, transcriptomic or epigenomic analysis, this approach allows the study of the underlying molecular mechanisms on different cellular models derived from affected individuals.These research efforts highlight the physiopathological impact of punctual and structural genetic variations on the transcriptional and post-transcriptional regulatory mechanisms of target genes and pave the way for new biological hypotheses in the context of translational research in human pathology
Sarkar, Abhishek Kulshreshtha. "Interpreting the role of non-coding genetic variation in human disease". Thesis, Massachusetts Institute of Technology, 2017. http://hdl.handle.net/1721.1/112026.
Testo completoCataloged from PDF version of thesis.
Includes bibliographical references (pages 101-107).
One of the fundamental goals of human genetics is to identify the genetic causes of human disease to ultimately design novel therapeutics. However, two challenges have become readily apparent. First, the majority of genomic regions associated with disease do not implicate protein-altering variants but might instead alter gene regulation, making interpretation and validation more difficult. Second, the genomic regions associated with disease explain a fraction of the variance of associated phenotypes, suggesting human diseases are highly polygenic and that many additional regions remain to be discovered and characterized. Here, we address these challenges by using functional annotation of the human genome spanning diverse data types: epigenomic profiles, gene regulatory circuitry, and biological pathways. We first develop a method to simultaneously select relevant genomic regions not yet associated with disease as well as select relevant functional annotations enriched in those regions. We show that both tissue-specific and shared regulatory regions are enriched for disease associations across eight common diseases. We then characterize specific genetic variants in the selected regions, the gene regulatory elements they reside in, the cellular contexts in which those elements are active, their upstream regulators, their downstream target genes, and the biological pathways they disrupt across eight common diseases. We show that disease associations are additionally enriched in regulatory motifs of relevant transcription factors and in relevant biological pathways. We finally investigate why predicted regulatory elements are enriched in disease-associated variants by framing the problem as Bayesian inference of hyperparameters in a structured sparse regression model. We propose an active sampling method to efficiently explore the hyperparameter space and avoid exponential scaling in the dimension of the hyperparameters. We show in simulation that our method can distinguish between possible explanations of the observed enrichments, and we characterize potential biases in the estimates. Together, our results can help guide the development of new models of disease and gene regulation and discovery of biologically meaningful, but currently undetectable regulatory loci underlying a number of common diseases.
by Abhishek Sarkar.
Ph. D.
Lomelin, David. "Using human genetic variation to predict functional elements in non-coding genomic regions". Diss., Search in ProQuest Dissertations & Theses. UC Only, 2010. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3390057.
Testo completoBarcons, Simon Anna. "Clonally variant non-coding RNA family and its role in Plasmodium falciparum antigenic variation". Electronic Thesis or Diss., Sorbonne université, 2019. https://accesdistant.sorbonne-universite.fr/login?url=https://theses-intra.sorbonne-universite.fr/2019SORUS042.pdf.
Testo completoAntigenic variation is an immune evasion mechanism used by the malaria parasite Plasmodium falciparum to establish prolonged infection. It prevents parasite clearance by switching the display of variant surface antigens encoded by the 60-member var gene family. Blood stage parasites express var genes in a mutually exclusive manner, with a single var active at a given time, ensuring that the immune system remains naive to a parasite sub-population. Despite multiple factors known to be involved in default var gene silencing, such as histone modifications and nuclear architecture, a specific activation factor has not been identified yet. In this thesis work, a polymerase III-transcribed family of GC-rich ncRNA was explored as a candidate regulatory factor of var gene activation. The GC-rich ncRNA family consists of 15 homologous members positioned adjacent to chromosome-central var genes. RNA FISH analysis revealed that the GC-rich ncRNA is targeted to the var expression site in trans. Overexpression of one GC-rich ncRNA member overrules singular var expression and induces transcription of a specific subset of var genes. We developed a dead Cas9 system aiming to target transcription of all GC-rich members. Strikingly, transcriptional blocking of all GC-rich members by CRISPR interference results in down-regulation of var transcription to background levels. Our data support a role of this ncRNA in the activation process of var genes. Moreover, we show that the GC-rich ncRNA gene family is clonally variant, indicating that this may determine switch rate and switch order of the var gene family. We developed a robust ChIRP (chromatin isolation by RNA purification) protocol that allowed us to identify potential chromatin binding regions and interacting partners of this ncRNA family. The validation of several promising candidate proteins obtained my mass spectrometry is ongoing. Furthermore, we investigated whether the gene loci of these ncRNAs display long-range interactions using a chromosome conformation capture technique. We obtained evidence that the gene loci of these ncRNAs display long-range interactions between them and can thus play a role in nuclear spatial foci organization. This study provides the first functional link between Pol III and Pol II transcription in the process of mutually exclusive expression of virulence genes. Moreover, exploring this ncRNA is a key step in unveiling the process of immune evasion and pathogenesis of P. falciparum
Christodoulou, Zoe. "An analysis of non-coding RNAs in Plasmodium falciparum and their potential role in antigenic variation". Thesis, University of Oxford, 2012. http://ora.ox.ac.uk/objects/uuid:60ea27e2-1129-4914-8abd-cfad018e0353.
Testo completoLi, Jia. "Identifier les variations conduisant au cancer dans le génome non codant et du transcriptome". Thesis, Université Paris-Saclay (ComUE), 2015. http://www.theses.fr/2015SACLS161/document.
Testo completoFunctional annotation of somatic mutations have been a consistent hotspot of cancer genomics studies. In the past, researchers preferentially focused on mutations in the coding fraction of the genome, for which ample bioinformatics tools were developed to distinguish cancer-driver mutations from neutral ones. In recent years, as an increasing number of variants were being identified as disease-associated in the non-coding genome, interpreting non-coding cancer mutations has become an urgent task. The completion of large scale projects such as ENCODE, has made functional interpretation of cancer variants achievable, and several programs were produced based on this functional information. However, there still exists some limitations as to these prediction tools, such as low prediction accuracy, lack of cancer mutation information and significant ascertainment bias. In chapter 2 of this thesis, in order to functionally interpret non-coding mutations in cancer, we developed two independent random forest models, referred to as SNP and SOM. Given a combination of features at a given genome positions, the SNP model predicts the expected fraction of rare SNPs (a measure of negative selection), and the SOM model predicts the expected mutation density at this position. We applied our two models to score these non-coding disease-associated clinvariant and HGMD variants and a set of random control SNPs. Results showed that disease-associated variants were scored higher than control SNPs with the SNP model and lower than control SNPs with the SOM model, supporting our hypothesis that purifying selection as measured by fraction of rare SNPs and mutation density is informative for the evaluation of the functional impact of cancer mutations in the non-coding genome. In the past, researchers have preferentially considered protein-coding genes as critical to the initiation and progression of cancers. However, recent evidences have shown that ncRNAs, in particular lncRNAs, are actively implicated in various cancer processes. A chapter of this thesis is devoted to this class of non-coding transcripts. Similar to protein coding genes, there might be a large number of lncRNAs with cancer-driving functions. The development of bioinformatics tools to prioritize them has become a new focus of research for computational oncologists.The last part of this thesis is devoted to the implementation of methods for discovering potential cancer-driving non-coding elements in lncRNA and protein-coding genes. We applied three scoring tools, CADD, funSeq2, GWAVA, together with our SNP and SOM scoring systems to prioritize cancer-associated elements using a permutation-based algorithm. For each locus, we compute the average score of all observed variants using one of the models, and we randomly take the same number of variants and compute their average score 1 million times to form a null distribution and obtain a P value for this locus. To validate our hypothesis and permutation model, we tested this system on 61 cancer-related lncRNA and 452 cancer genes using somatic mutation data from liver cancer, lung cancer, CLL and melanoma. We observed that both cancer lncRNAs and protein-coding genes had significantly lower average P values than total lncRNAs and protein-coding genes in all cases. Applying the permutation test to lncRNAs with five different scoring systems enabled us to prioritize hundreds to thousands of cancer-related lncRNA candidates. These candidates can be used for future experimental validation
Lalaouna, David. "Role d' ARN non codants régulateurs dans l' adaptation de Pseudomonas brassicacearum à la rhizosphère et aux fluctuations de l' environnement". Thesis, Aix-Marseille, 2012. http://www.theses.fr/2012AIXM4006.
Testo completoThe plant-beneficial bacterium Pseudomonas brassicacearum forms phenotypic variants in vitro as well as in planta during root colonisation under natural conditions. Transcriptome analysis of typical phenotypic variants using microarrays containing coding as well as non-coding DNA fragments showed differential expression of several genes relevant to secondary metabolism and of the small non-coding RNA (ncRNA) genes rsmX, rsmY and rsmZ, which was characterized by down-regulation. Naturally occurring mutations in the GacS/GacA two-component system accounted for phenotypic switching. The importance of these ncRNAs in the survival of the bacteria to changing environments is denoted by the duplication of rsmX gene, which we called rsmX-2 and whose function has been validated. Our data suggest an exclusive activation of rsmX-1 and rsmX-2 genes by GacA and the involvement of additional regulators in the case of rsmY and rsmZ. Given the functional redundancy of these ncRNAs, we investigated their expression level and stability in different culture conditions and showed differences for the four ncRNAs. In response to nutrient depletion, the four ncRNAs expression is strongly activated and reaches its maximum when the ppGpp is detected in bacterial cells, suggesting a link between the Gac/Rsm system and the "stringent" response. Determining the level of each Rsm ncRNA, which is defined by a balance between synthesis and degradation of each transcript, shows the maintenance of a very important pool of RsmZ compared to other ncRNAs
Diffendall, Gretchen. "Deciphering the role of an RNA Pol III-transcribed non-coding RNA in Plasmodium falciparum". Electronic Thesis or Diss., Sorbonne université, 2022. https://accesdistant.sorbonne-universite.fr/login?url=https://theses-intra.sorbonne-universite.fr/2022SORUS443.pdf.
Testo completoThe protozoan parasite Plasmodium falciparum is the causative agent of the deadliest form of human malaria. This pathogen uses monoallelic expression of variant surface adhesion molecules, encoded by the var gene family, to evade the host immune system and cause pathogenesis. It remains unclear how monoallelic expression of var gene activation works at the molecular level and if environmental factors can modulate var gene expression. Our laboratory showed a Pol III transcribed GC-rich non-coding RNA gene family, termed RUF6, acts as a trans-activator of var genes. A physical association between the transcribed RUF6 ncRNA and the active var gene locus was observed through FISH. Transcriptional repression of all RUF6 by a specific CRISPR interference strategy resulted in transcriptional down regulation of the entire var gene family, suggesting a potential enhancer-like function to var gene expression. An understanding of how RUF6 ncRNA mediates var gene activation is lacking. Here we developed a robust RNA-directed proteomic discovery (ChIRP-MS) protocol to identify in vivo RUF6 ncRNA protein interactions. Biotinylated antisense oligonucleotides were used to purify the RUF6 ncRNA interactome. Mass spectrometry identified several uniquely enriched proteins that are linked to gene transcription such as RNA Pol II subunits, nucleosome assembly proteins, and a homologue of the Dead-Box Helicase 5 (DDX5). Affinity purification of PfDDX5 identified several proteins originally found by our RUF6-ChIRP protocol, validating the robustness of the technique for the identification of ncRNA interactomes in P. falciparum. Inducible displacement of nuclear Pf-DDX5 resulted in the significant down-regulation of the active var gene. Our work identifies a RUF6 ncRNA protein complex that interacts with RNA Pol II to sustain var gene expression. We postulate that DDX5 helicase may resolve G-quadruplex secondary structures highly enriched in var genes to facilitate transcriptional activation and progression. Furthermore, we discovered environmental factors that trigger downregulation of var gene transcription. We observe that isoleucine starvation and high MgCl2 concentrations in the medium inhibit RNA Polymerase III transcribed genes. Importantly, this includes a P. falciparum-specific regulatory ncRNA gene family (encoded by the RUF6 gene family) that is a key regulator in var gene activation. We identified a homologous gene to the highly conserved eukaryotic Maf1, as a negative effector of RUF6 ncRNA transcription. Elevated MgCl2 concentrations led to a shift of cytoplasmic PfMaf1 to the nuclear compartment. We used an inducible protein degradation system to show that external stimuli depend on PfMaf1 to trigger lower expression of RUF6 genes. Our results point to a TOR independent pathway that responds to changes in the environment and represses Pol III transcription. This work provides new and important conceptual insights into PfMaf1-dependent repression of parasite virulence that may be highly relevant for establishing subclinical parasite persistence in the dry season. Taken together, these results help to better understand the function and regulation of a ncRNA involved in regulating the antigenic variation and pathogenesis in P. falciparum. Our validation of the ChIRP-MS technique allows for future studies in identifying RNA-binding proteins for ncRNAs whose function remains to be fully characterized
Lundmark, Per Erik. "Genetic and Genomic Analysis of DNA Sequence Variation". Doctoral thesis, Uppsala universitet, Molekylär medicin, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-158486.
Testo completoLibri sul tema "Non coding variations"
Yang, Jin, Pei Han, Wei Li e Ching-Pin Chang. Epigenetics and post-transcriptional regulation of cardiovascular development. A cura di José Maria Pérez-Pomares, Robert G. Kelly, Maurice van den Hoff, José Luis de la Pompa, David Sedmera, Cristina Basso e Deborah Henderson. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198757269.003.0032.
Testo completoBroad-scale variation in human genetic diversity levels is predicted by purifying selection on coding and non-coding elements. [New York, N.Y.?]: [publisher not identified], 2021.
Cerca il testo completoRucker, James J. H., e Peter McGuffin. Copy Number Variation in Neuropsychiatric Disorders. A cura di Turhan Canli. Oxford University Press, 2013. http://dx.doi.org/10.1093/oxfordhb/9780199753888.013.005.
Testo completoCapitoli di libri sul tema "Non coding variations"
Koksoy, Hale. "The Role of Genetics and Epigenetics in Diabetes Progress." In Current Multidisciplinary Approach to Diabetes Mellitus Occurrence Mechanism, 1–13. Istanbul: Nobel Tip Kitabevleri, 2023. http://dx.doi.org/10.69860/nobel.9786053359104.1.
Testo completoHeers, Josef, Christoph Schnörr e H. Siegfried Stiehl. "A Class of Parallel Algorithms for Nonlinear Variational Segmentation: A preprocess for robust feature-based image coding". In Noblesse Workshop on Non-Linear Model Based Image Analysis, 146–51. London: Springer London, 1998. http://dx.doi.org/10.1007/978-1-4471-1597-7_23.
Testo completoSchulze-Bahr, Eric. "Basic principles of genetic disease". In ESC CardioMed, 669–71. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198784906.003.0148.
Testo completoAlhamdan, Rana. "Would Non-coding RNA Resolve the Polycystic Ovary Syndrome (PCOS) Puzzle?" In Polycystic Ovary Syndrome - Symptoms, Causes and Treatment [Working Title]. IntechOpen, 2024. http://dx.doi.org/10.5772/intechopen.114387.
Testo completoD. Magar, Nakul, Priya Shah, K. Harish, Tejas C. Bosamia, Kalyani M. Barbadikar, Yogesh M. Shukla, Amol Phule et al. "Gene Expression and Transcriptome Sequencing: Basics, Analysis, Advances". In Gene Expression [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.105929.
Testo completoIqbal, Nashra, Priyanka Vishwakarma e Vidya Meenakshi. "NEXT GENERATION SEQUENCING FOR CANCER DIAGNOSIS". In Futuristic Trends in Biotechnology Volume 3 Book 21, 137–51. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bkbt21p1ch11.
Testo completoFerguson, Rex. "Secretions". In Identification Practices in Twentieth-Century Fiction, 119–58. Oxford University Press, 2021. http://dx.doi.org/10.1093/oso/9780198865568.003.0004.
Testo completoKoinova, Maria. "The Microfoundations". In Diaspora Entrepreneurs and Contested States, 61–94. Oxford University Press, 2021. http://dx.doi.org/10.1093/oso/9780198848622.003.0003.
Testo completoCreissels, Denis. "Transitive coding and valency". In Transitivity, Valency, and Voice, 275–316. Oxford University PressOxford, 2024. http://dx.doi.org/10.1093/9780198899594.003.0007.
Testo completoNei, Masatoshi, e Sudhir Kumar. "Evolutionary Change of DNA Sequences". In Molecular Evolution and Phylogenetics, 33–50. Oxford University PressNew York, NY, 2000. http://dx.doi.org/10.1093/oso/9780195135848.003.0003.
Testo completoAtti di convegni sul tema "Non coding variations"
"Interpreting non-coding genome variation with DNA sequence motifs". In Bioinformatics of Genome Regulation and Structure/Systems Biology (BGRS/SB-2022) :. Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences, 2022. http://dx.doi.org/10.18699/bgrs/sb-2022-038.
Testo completo"Interpreting non-coding genome variation with DNA sequence motifs". In Bioinformatics of Genome Regulation and Structure/Systems Biology (BGRS/SB-2022) :. Institute of Cytology and Genetics, the Siberian Branch of the Russian Academy of Sciences, 2022. http://dx.doi.org/10.18699/sbb-2022-038.
Testo completoHolik, A., e S. Ossowski. "PO-348 The other 98%: making sense of non-coding variation". In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.378.
Testo completoBaross, Stephanie, Simon Williams, Kathryn Hentges, Andrew Sharrocks e Bernard Keavney. "BS54 Variation in cardiac long non-coding rnas in congenital heart disease". In British Cardiovascular Society Annual Conference ‘Digital Health Revolution’ 3–5 June 2019. BMJ Publishing Group Ltd and British Cardiovascular Society, 2019. http://dx.doi.org/10.1136/heartjnl-2019-bcs.215.
Testo completoUmu, SU, R. Lyle, H. Langseth e TB Rounge. "PO-096 Natural variation in serum small non-coding RNAs – potential biomarkers of cancer". In Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/esmoopen-2018-eacr25.623.
Testo completoBuchsbaum, Gershon. "Optimal coding of spatiochromatic information in the retina". In OSA Annual Meeting. Washington, D.C.: Optica Publishing Group, 1986. http://dx.doi.org/10.1364/oam.1986.tuf2.
Testo completoBorn, Werner, e Linda Schmidt. "Evaluating the Project Activity Differences in Capstone Design Students via Journals". In ASME 2018 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2018. http://dx.doi.org/10.1115/detc2018-85876.
Testo completoLawrenson, Kate, Honglin Song, Janet Lee, Jonathan Tyrer, Susan Ramus, Paul Pharoah e Simon Gayther. "Abstract 2559: Long non-coding RNAs as functional targets of germline genetic variation at ovarian cancer susceptibility loci." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2559.
Testo completo"Identification and variation analysis of long non-coding RNA genes expressed at early stages of seed development in Triticale". In Plant Genetics, Genomics, Bioinformatics, and Biotechnology. Novosibirsk ICG SB RAS 2021, 2021. http://dx.doi.org/10.18699/plantgen2021-043.
Testo completoSilva, Bruno S. da, e Iury da S. Batalha. "Measurement Study on 5G NSA Architecture over Fading Channel". In 11th International Conference on Signal & Image Processing (SIP 2022). Academy and Industry Research Collaboration Center (AIRCC), 2022. http://dx.doi.org/10.5121/csit.2022.121703.
Testo completoRapporti di organizzazioni sul tema "Non coding variations"
Hanslow, Kevin. A General Welfare Decomposition for CGE Models. GTAP Technical Paper, marzo 2001. http://dx.doi.org/10.21642/gtap.tp19.
Testo completoNelson, Gena. A Systematic Review of the Quality of Reporting in Mathematics Meta-Analyses for Students with or at Risk of Disabilities Coding Protocol. Boise State University, luglio 2021. http://dx.doi.org/10.18122/sped138.boisestate.
Testo completoNelson, Gena. A Systematic Review of the Quality of Reporting in Mathematics Meta-Analyses for Students with or at Risk of Disabilities Coding Protocol. Boise State University, Albertsons Library, luglio 2021. http://dx.doi.org/10.18122/sped.138.boisestate.
Testo completoGinzberg, Idit, Richard E. Veilleux e James G. Tokuhisa. Identification and Allelic Variation of Genes Involved in the Potato Glycoalkaloid Biosynthetic Pathway. United States Department of Agriculture, agosto 2012. http://dx.doi.org/10.32747/2012.7593386.bard.
Testo completoCohen, Deborah J., Annette M. Totten, Robert L. Phillips, Jr., Yalda Jabbarpour, Anuradha Jetty, Jennifer DeVoe, Miranda Pappas, Jordan Byers e Erica Hart. Measuring Primary Healthcare Spending. Agency for Healthcare Research and Quality (AHRQ), maggio 2024. http://dx.doi.org/10.23970/ahrqepctb44.
Testo completoBennett, Alan B., Arthur A. Schaffer, Ilan Levin, Marina Petreikov e Adi Doron-Faigenboim. Manipulating fruit chloroplasts as a strategy to improve fruit quality. United States Department of Agriculture, gennaio 2013. http://dx.doi.org/10.32747/2013.7598148.bard.
Testo completo